NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $116.56 -1.31 (-1.11%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$116.55 -0.01 (-0.01%) As of 05/22/2026 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iRhythm Technologies Stock (NASDAQ:IRTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iRhythm Technologies alerts:Sign Up Key Stats Today's Range$112.86▼$123.1550-Day Range$110.94▼$129.1652-Week Range$108.81▼$212.00Volume462,964 shsAverage Volume580,839 shsMarket Capitalization$3.83 billionP/E RatioN/ADividend YieldN/APrice Target$191.85Consensus RatingModerate Buy Company Overview iRhythm Technologies, Inc. is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians. The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders. After wearing the water-resistant patch, patients mail it back to iRhythm’s central lab, where recorded data are analyzed using the company’s AI-powered architecture. A comprehensive report, including annotated ECG strips and rhythm diagnosis, is delivered directly to the prescribing clinician, helping to guide treatment decisions. iRhythm primarily serves the United States market through partnerships with hospitals, clinics and diagnostic laboratories, and the company has been expanding its global footprint through strategic collaborations and regulatory approvals in select international markets. Leadership is headed by President and Chief Executive Officer Kevin King, who has overseen product innovation and process enhancements to support scalable growth. iRhythm continues to invest in research and development to extend its diagnostic platform into emerging areas of cardiovascular care and digital health.AI Generated. May Contain Errors. Read More iRhythm Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreIRTC MarketRank™: iRhythm Technologies scored higher than 82% of companies evaluated by MarketBeat, and ranked 85th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingiRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 2 strong buy ratings, 11 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialiRhythm Technologies has a consensus price target of $191.85, representing about 64.6% upside from its current price of $116.56.Amount of Analyst CoverageiRhythm Technologies has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth907.69% Earnings GrowthEarnings for iRhythm Technologies are expected to grow by 907.69% in the coming year, from $0.13 to $1.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -135.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -135.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 23.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted8.77% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 6.63.Change versus previous monthShort interest in iRhythm Technologies has recently decreased by 5.45%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.08 News SentimentiRhythm Technologies has a news sentiment score of -0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for iRhythm Technologies this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold 20,922.70% more of their company's stock than they have bought. Specifically, they have bought $56,892.00 in company stock and sold $11,960,237.00 in company stock.Percentage Held by Insiders0.98% of the stock of iRhythm Technologies is held by insiders.Percentage Held by InstitutionsiRhythm Technologies has minimal institutional ownership at this time.Read more about iRhythm Technologies' insider trading history. Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRTC Stock News HeadlinesiRhythm Holdings to Participate in Upcoming Investor ConferencesMay 19, 2026 | globenewswire.comiRhythm Technologies (NASDAQ:IRTC) Price Target Cut to $180.00 by Analysts at Bank of AmericaMay 19, 2026 | americanbankingnews.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.May 24 at 1:00 AM | Profits Run (Ad)Bank of America Securities Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)May 15, 2026 | theglobeandmail.comiRhythm Holdings, Inc. (IRTC) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13, 2026 | seekingalpha.comInsider Buying: iRhythm Technologies (NASDAQ:IRTC) Director Buys 5,312 Shares of StockMay 13, 2026 | insidertrades.comiRhythm Holdings, Inc. 2026 Q1 - Results - Earnings Call PresentationMay 4, 2026 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Apogee Therapeutics (APGE)May 3, 2026 | theglobeandmail.comSee More Headlines IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $177.44 at the beginning of the year. Since then, IRTC shares have decreased by 34.3% and is now trading at $116.56. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies (NASDAQ:IRTC) posted its earnings results on Thursday, April, 30th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.56) by $0.21. The company's revenue was up 25.6% on a year-over-year basis. Read the conference call transcript. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $88 million in an IPO on Thursday, October 20th 2016. The company issued 6,294,118 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' top institutional shareholders include Arrowstreet Capital Limited Partnership (1.77%), Stephens Investment Management Group LLC (1.71%), Allspring Global Investments Holdings LLC (1.42%) and Bank of America Corp DE (1.32%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Patrick Michael Murphy, Chad Patterson, Minang Turakhia, Sumi Shrishrimal, Daniel G Wilson, Mervin Smith, Abhijit Y Talwalkar, Brice Bobzien, Marc Wade Rosenbaum and Marc W Rosenbaum. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings4/30/2026Today5/24/202646th Annual William Blair Growth Stock Conference6/02/2026Truist Securities MedTech Conference 20266/16/2026Next Earnings (Estimated)7/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 IRTC's financial health is in the Red zone, according to TradeSmith. IRTC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRTC CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,400Year Founded2006Price Target and Rating Average Price Target for iRhythm Technologies$191.85 High Price Target$255.00 Low Price Target$147.00 Potential Upside/Downside+64.6%Consensus RatingModerate Buy Rating Score (0-4)2.93 Research Coverage15 Analysts Profitability EPS (Trailing Twelve Months)($0.86) Trailing P/E RatioN/A Forward P/E Ratio896.62 P/E GrowthN/ANet Income-$44.55 million Net Margins-3.53% Pretax Margin-3.43% Return on Equity-10.26% Return on Assets-1.39% Debt Debt-to-Equity Ratio4.03 Current Ratio5.17 Quick Ratio4.98 Sales & Book Value Annual Sales$747.14 million Price / Sales5.13 Cash FlowN/A Price / Cash FlowN/A Book Value$4.91 per share Price / Book23.74Miscellaneous Outstanding Shares32,860,000Free Float32,540,000Market Cap$3.83 billion OptionableOptionable Beta1.33 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:IRTC) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
